Presentation of MUC1 Tumor Antigen by Class I MHC and CTL Function Correlate with the Glycosylation State of the Protein Taken Up by Dendritic Cells
- 15 June 1999
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 194 (2) , 143-149
- https://doi.org/10.1006/cimm.1999.1512
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Screening of anti-MUC1 antibodies for reactivity with native (ascites) and recombinant (baculovirus) MUC1 and for blocking MUC1 specific cytotoxic T-lymphocytes.Tumor Biology, 1998
- T CELL RECEPTOR ??-CHAIN REPERTOIRES ARE NONRANDOMLY SELECTED IN RESPONSES TO HLA-DR11Transplantation, 1996
- A new foreign policy: MHC class I molecules monitor the outside worldImmunology Today, 1996
- Human Tumor Antigens Are Ready to FlyPublished by Elsevier ,1996
- Epithelial Mucin GenesAnnual Review of Physiology, 1995
- Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunityNature Medicine, 1995
- MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer VaccinesImmunological Reviews, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- T CELL RECEPTOR Vβ GENE USAGE IN ALLOGRAFT-DERIVED CELL LINES ANALYZED BY A POLYMERASE CHAIN REACTION TECHNIQUE1Transplantation, 1992
- Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.Proceedings of the National Academy of Sciences, 1989